2017
DOI: 10.1002/14651858.cd003614.pub3
|Get access via publisher |Summarize |Cite
|
Sign up to set email alerts

Trimetazidine for stable angina

Abstract: The editorial group responsible for this previously published document have withdrawn it from publication.

Search citation statements

Order By: Relevance

Paper Sections

Select...
95
4
3
0

Citation Types

0
26
0
9

Year Published

Range
2006
2006
2024
2024

Publication Types

Select...
89
9
1
1

Relationship

0
100

Authors

Journals

citations

Cited by 100 publications

(35 citation statements)
references

References 101 publications

0
26
0
9
Order By: Relevance
How this paper cites the one you are viewing
“…Trimetazidine has been reported, in some studies, to be better tolerated than combined antianginal therapy. 6 In the context of above guidelines recommendations, findings of this survey showed that majority of HCPs preferred β-blockers and nitrates as the first-line therapy followed by trimetazidine and indicated that majority of HCPs preferred trimetazidine CR 35 mg BD for their angina patients.…”
Section: Discussion
mentioning
confidence: 89%